CMA Greenlights BaraSeen Medical's 3.3M Share IPO on Nomu

The Capital Market Authority approved BaraSeen Medical Co.'s initial public offering of 3.3 million shares on the Nomu parallel market. The regulator's board of directors gave the green light for the offering, the CMA said in a statement. BaraSeen would list its shares on Nomu, Saudi Arabia's alternative exchange designed for smaller companies.

Nomu, launched in 2017, has lower listing requirements than the main Tadawul board. Companies use it to raise capital with fewer disclosure obligations. The market also permits higher daily price swings, attracting a mix of retail and institutional investors. BaraSeen's planned offering size of 3.3 million shares is moderate by Nomu standards.

The medical sector has been a focus area under Saudi Arabia's Vision 2030 plan, with the government pushing for increased private sector participation. BaraSeen operates in this space, though the company has not disclosed specifics on how it will use the IPO proceeds. The CMA review likely covered financial health, governance, and shareholder structure.

The approval triggers a sequence of steps. BaraSeen must publish a prospectus with a price range and open the subscription period. Investors on Nomu typically have a short window to place orders. The final listing date depends on demand and the underwriter's schedule. The offering is subject to final approval from the Nomu listing committee.